US researcher with mosquito saliva vaccine to prevent mosquito-borne infections. Jessica Manning is a researcher with information about the first clinical trial of the vaccine, published in The Lancet.
The vaccine is said to be capable of fighting malaria, chickenpox, dengue, Zika, yellow fever, West Nile and Mayaro virus.
Jessica is a clinical researcher at the US National Institute of Allergy and Infectious Diseases. The main goal of Jessica and her team is to produce the vaccine using mosquito saliva protein.